Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Cheng Cao, Qin Guo, Yaping Dai, Junfeng Jiang, Min Liu, Tuo Ji, Pengcheng Zhou & Fang Gong. (2023) Neutralizing activity of a third dose of CoronaVac against Omicron subvariants within a 20-month follow-up study. Human Vaccines & Immunotherapeutics 19:2.
Read now
Read now
Articles from other publishers (4)
Ana María Salinas-Martínez, Edgar P. Rodríguez-Vidales, Denise Garza-Carrillo, Olivia A. Robles-Rodríguez, Roberto Montes de Oca-Luna & Alma Rosa Marroquín-Escamilla. (2023) Comparison of the effectiveness of four SARS-COV-2 v accines in Nuevo Leon, Mexico: A test-negative control study. Atención Primaria 55:5, pages 102606.
Crossref
Crossref
Qianying Wang, Shuhui Wang, Ying Liu, Shuo Wang, Hong Peng, Yanling Hao, Kunxue Hong, Dan Li & Yiming Shao. (2023) Sequential Administration of SARS-CoV-2 Strains-Based Vaccines Effectively Induces Potent Immune Responses against Previously Unexposed Omicron Strain. Pathogens 12:5, pages 655.
Crossref
Crossref
Yuxiao Wang, Ying Qiao, Yuqi Huo, Li Wang, Shijie Liang, Maohe Yu, Xinquan Lan, Moxin Song, Xiangjun Zhang, Ying Yan & Junjie Xu. (2023) The safety and immunogenicity of a two-dose schedule of CoronaVac, and the immune persistence of vaccination for six months, in people living with HIV: A multicenter prospective cohort study. Frontiers in Immunology 14.
Crossref
Crossref
Thanyarat Promlek, Tonsan Hansirisathit, Jadsada Kunno & Maytawan Thanunchai. (2023) The Effects of CoronaVac and ChAdOx1 nCoV-19 in Reducing Severe Illness in Thailand: A Retrospective Cohort Study. Tropical Medicine and Infectious Disease 8:2, pages 95.
Crossref
Crossref